The Latin America point-of-care diagnostics market is projected to grow to $1.15 billion by 2031, expanding at a compound annual growth rate of 7.9% from 2026 to 2031, according to a new report published by MarketsandMarkets.
The market was valued at $0.75 billion in 2025 and increased to $0.79 billion in 2026, reflecting rising demand for rapid diagnostic solutions to address the region’s growing burden of infectious and chronic diseases. Improved healthcare infrastructure, increased public and private investment in decentralized testing, and wider access to near-patient diagnostic technologies are key contributors to this growth.
Point-of-care diagnostics are increasingly being adopted across hospitals, clinics, pharmacies, community health centers and home care settings to support faster clinical decision-making and reduce reliance on centralized laboratories. The report notes that self-testing and home-based diagnostics are gaining traction as healthcare systems seek cost-effective, patient-centric solutions and improved access in remote and underserved areas.
Key findings from the report include:
-
Infectious disease diagnostics is expected to be the fastest-growing product segment, posting a 9.5% CAGR through 2031, driven by rising cases of respiratory infections, sexually transmitted diseases and hospital-acquired infections.
-
Prescription-based testing products are forecast to grow at a 9.1% CAGR, supported by regulatory oversight and physician confidence in clinically validated point-of-care tests.
-
Biochemistry-based technologies accounted for the largest market share at 59.7% in 2025, reflecting their widespread use in glucose monitoring and cardiometabolic testing.
-
Blood-based tests represented the largest share by sample type in 2025 due to their critical role in chronic disease monitoring.
-
Home care settings and self-testing are expected to be the fastest-growing end-user segment as patients increasingly prefer convenient, decentralized testing options.
Brazil is expected to remain the fastest-growing country market in the region, supported by expanding primary healthcare infrastructure, rising healthcare investment, and a growing prevalence of infectious and chronic diseases.
The competitive landscape includes established global players such as Abbott, F. Hoffmann-La Roche Ltd., Siemens, QuidelOrtho and Danaher Corporation, alongside emerging companies including ModiTech Med and Response Biotech, which are gaining traction in niche segments.
Despite strong growth prospects, the market faces challenges related to pricing pressure, reimbursement constraints and inconsistent standardization compared with centralized laboratory testing. However, increasing adoption of portable diagnostic devices, favorable government initiatives and growing emphasis on early disease detection are expected to offset these barriers over the forecast period.
The report, titled “Latin America Point of Care Diagnostics Market by Product, Purchase Mode, Technology, Sample, End User – Forecast to 2031,” spans 200 pages and provides detailed analysis across products, technologies, end users and countries, including Brazil, Mexico and the rest of Latin America.